Synonyms:
Status: Phase 3
Entry Type: Small molecule
Molecule Category: UKNOWN
UNII: 8375F9S90C

Structure

InChI Key DENYZIUJOTUUNY-MRXNPFEDSA-N
Smile C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34
InChI
InChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C16H15FN4O
Molecular Weight 298.32
AlogP 2.08
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 0.0
Polar Surface Area 60.49
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 22.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Poly [ADP-ribose] polymerase-1 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Ovarian Neoplasms 3 D010051 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Glioblastoma 1 D005909 ClinicalTrials
Central Nervous System Neoplasms 1 D016543 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4112930
DrugBank DB14769
FDA SRS 8375F9S90C
PDB DS9
SureChEMBL SCHEMBL15084918
ZINC ZINC000150196116